C07K 16/089
Cytomegalovirus
Official title: {Cytomegalovirus}
C07K16/089 (Cytomegalovirus) appears on 119 US grants and 142 published applications in this corpus.
Search patents in C07K- Granted patents
- 119
- Published applications
- 142
- Assignees
- 81
- Inventors
- 276
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 1 |
| 2002 | 0 | 1 |
| 2003 | 1 | 2 |
| 2004 | 0 | 4 |
| 2005 | 2 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 4 |
| 2009 | 1 | 4 |
| 2010 | 2 | 4 |
| 2011 | 3 | 5 |
| 2012 | 9 | 11 |
| 2013 | 6 | 9 |
| 2014 | 4 | 8 |
| 2015 | 7 | 8 |
| 2016 | 8 | 13 |
| 2017 | 6 | 7 |
| 2018 | 4 | 9 |
| 2019 | 3 | 3 |
| 2020 | 4 | 7 |
| 2021 | 5 | 9 |
| 2022 | 6 | 8 |
| 2023 | 2 | 9 |
| 2024 | 4 | 7 |
| 2025 | 4 | 6 |
| 2026 | 5 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals26 May 2026US 12,637,495 B2Molecular Templates, Inc.
- Chimeric antigen receptors against human cytomegalovirus12 May 2026US 12,624,083 B2City of Hope
- Systems to produce B cells genetically modified to express selected antibodies31 Mar 2026US 12,589,145 B2Fred Hutchinson Cancer Center
- Fusion antibody for presenting antigen-derived T cell antigen epitope or peptide containing same on cell surface, and composition comprising same31 Mar 2026US 12,590,156 B2Ajou University Industry-Academic Cooperation Foundation
- Fusion antibody for presenting antigen-derived T cell antigen epitope or peptide containing same on cell surface, and composition comprising same17 Feb 2026US 12,551,733 B2Ajou University Industry-Academic Cooperation Foundation
- Methods and compositions comprising purified recombinant polypeptides1 Oct 2026US 2026/0297179 A1Genentech, Inc.
- Human ipsc-derived brain organoids and uses thereof12 Mar 2026US 2026/0069680 A1City of Hope
- Therapeutic and diagnostic agents and uses thereof25 Sep 2025US 2025/0296984 A1Thelper AS
- Application of hcmv gp34- and gp68-specific antibodies and fragments thereof for prevention, therapy and diagnostics of hcmv disease28 Aug 2025US 2025/0270295 A1Albert-Ludwigs-Universitaet Freiburg
- Cmv-hiv specific chimeric antigen receptor t cells7 Aug 2025US 2025/0249102 A1City of Hope
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Humanized immunoglobulins and methods of making the same1,467US 6,180,370 B2Protein Design Labs, Inc. · 2001
- Polynucleotides encoding improved humanized immunoglobulins1,258US 5,693,761 AProtein Design Labs, Inc. · 1997